Stay updated on Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-04-30T14:23:41.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The date has been updated from February 25, 2025, to April 22, 2025.
    Difference
    0.6%
    Check dated 2025-04-23T13:41:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1.0%
    Check dated 2025-04-16T11:03:53.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4 and has changed the date from 2025-03-25 to 2025-02-25.
    Difference
    0.6%
    Check dated 2025-04-09T05:17:49.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page has updated the reference to Seagen, clarifying its relationship as a subsidiary of Pfizer, and has changed a date from November 13, 2024, to February 25, 2025.
    Difference
    3%
    Check dated 2025-03-03T23:06:42.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T20:16:14.000Z thumbnail image

Stay in the know with updates to Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tucatinib vs. Placebo with T-DM1 in HER2+ Breast Cancer Clinical Trial page.